Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stem cell research hits the French political agenda

This article was originally published in Clinica

Executive Summary

Embyronic stem cell research has risen to the top of the French political agenda, one month after both Houses of the UK Parliament voted in favour of using this ethically sensitive technique (see Clinica No 943, p 5). But with a presidential election next year, the French politicians are treating the delicate subject with extreme caution. As the President, Jacques Chirac, and the Prime Minister, Lionel Jospin, represent opposing views, the parliamentary debate could be long and slow.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070041

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel